Human IgG antibody Laboratories manufactures the tissue tek oct tom compound reagents distributed by Genprice. The Tissue Tek Oct Tom Compound reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact tissue tek compound. Other Tissue products are available in stock. Specificity: Tissue Category: Tek Group: Oct Tom
Tom 40 Blocking Peptide |
|||
| 33R-10910 | Fitzgerald | 50 ug | EUR 191 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Tom 40 antibody, catalog no. 70R-12044 |
|||
Tom 40 Blocking Peptide |
|||
| 3740BP-50 | Biovision | EUR 153 | |
Polyclonal Tom 40 Antibody |
|||
| APR10502G | Leading Biology | 0.1mg | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Tom 40 . This antibody is tested and proven to work in the following applications: |
|||
Compound 401 |
|||
| B7337-10 | ApexBio | 10 mg | EUR 224 |
Compound 401 |
|||
| B7337-25 | ApexBio | 25 mg | EUR 441 |
Compound 401 |
|||
| B7337-5 | ApexBio | 5 mg | EUR 180 |
Compound W |
|||
| A4401-50 | ApexBio | 50 mg | EUR 177 |
|
Description: Inhibitor of ?-secretase; causes a decrease in the released levels of A?42 and notch-1 A?-like peptide 25 (N?25). |
|||
Compound 56 |
|||
| A8197-.5 | ApexBio | 500 µg | EUR 108 |
|
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM. |
|||
Compound 56 |
|||
| A8197-5 | ApexBio | 5 mg | EUR 224 |
|
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM. |
|||
Compound 56 |
|||
| A8197-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 270 |
|
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM. |
|||
Compound 56 |
|||
| A8197-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM. |
|||
Compound W |
|||
| 2208-250 | Biovision | EUR 300 | |
Compound W |
|||
| 2208-50 | Biovision | EUR 115 | |
Compound 112254 |
|||
| 2573-25 | Biovision | EUR 588 | |
Compound 112254 |
|||
| 2573-5 | Biovision | EUR 185 | |
Compound 401 |
|||
| 1657-5 | Biovision | EUR 238 | |
Compound 1 |
|||
| 1688-5 | Biovision | EUR 207 | |